Disease relevance of Brucellosis, Bovine

• PHE1 is a htrA cycL double gene deletion mutant of virulent Brucella abortus strain 2308 (S2308) which has previously been evaluated in the murine and caprine models of bovine brucellosis [1].
• 13, 0.013, and 0.029%, respectively; the prevalence of anthrax and echinococcosis was 0.012 and 0.007%, respectively; and finally, the prevalence of bovine brucellosis was 8% in the peri-urban areas [2].

High impact information on Brucellosis, Bovine

• These findings provide a basis for the use of trehalose dimycolate and muramyl dipeptide adjuvants in evaluating nonviable vaccines for bovine brucellosis [3].
• This study evaluated the buffered plate antigen test (BPA), now used to screen for bovine brucellosis, as a screen for human disease [4].
• The Nramp1 gene, which participates in the innate response, is related to susceptibility and protection in bovine brucellosis [5].
• Eradication of bovine brucellosis in the 10th Region de Los Lagos, Chile [6].
• The reduced O-chain content in RB51 prevents this bacterium from inducing antibodies detectable by the conventional serologic tests for bovine brucellosis diagnosis that mainly identify antibodies to LPS [7].

Chemical compound and disease context of Brucellosis, Bovine

• Assessment of the EDTA seroagglutination test for the diagnosis of bovine brucellosis [8].
• Brucellergene OCB (Rhône-Mérieux) was used as an allergen to define the intrinsic parameters of a skin test and to compare its properties with serology for the diagnosis of bovine brucellosis [9].
• Efficacy of long-acting oxytetracycline alone or combined with streptomycin in the treatment of bovine brucellosis [10].
• Prozones and delayed reactions in the rose bengal test for bovine brucellosis [11].
• A simple method for the extraction of polysaccharide B from Brucella cells for use in the radial immunodiffusion test diagnosis of bovine brucellosis [12].

Gene context of Brucellosis, Bovine

• The use of the non-specific immunological factors, conglutinin, immunoconglutinin and heterophile antibody, in the serodiagnosis of bovine brucellosis [13].
• Soluble salt-extractable protein antigens (CSP) from Brucella abortus may be of potential value as a vaccine and as a diagnostic reagent for the prevention and diagnosis of bovine brucellosis [14].

Analytical, diagnostic and therapeutic context of Brucellosis, Bovine

• With the aid of a horseradish peroxidase (HRP) tagged monoclonal antibody against smooth lipopolysaccharide from Brucella abortus (Bruce 1), a competitive and superimposable ELISA test procedure for bovine brucellosis has been evaluated for its ability to discriminate between Strain 19-vaccinated (S19-Vacc) and Biotype 1-infected (B1-Inf) cattle [15].
• The use of EDTA in the microtitration serum agglutination test in bovine brucellosis [16].
• Use of dried smooth lipopolysaccharide antigen coated polystyrene plates for diagnosis of bovine brucellosis by enzyme immunoassay [17].

References